On Tuesday, Blackstone Mortgage Trust Inc (NYSE:BXMT)’s shares declined -2.31% to $30.39, as Blackstone Mortgage Trust, declared the pricing of an underwritten public offering of 20,000,000 shares of its class A ordinary stock at a public offering price of $30.50 per share. The offering was upsized from 17,500,000 shares to 20,000,000 shares. The underwriters have been granted a 30-day option by the Corporation to purchase up to an additional 3,000,000 shares. The offering is predictable to close on April 17, 2015 and is subject to customary closing conditions. The offering will generate gross proceeds of about $610.0 million, or about $701.5 million if the underwriters exercise their option to purchase additional shares in full.
Blackstone Mortgage Trust, Inc., a real estate finance corporation, originates and purchases senior loans collateralized by properties in North America and Europe. It operates through two segments, Loan Origination and CT Legacy Portfolio.
Graphic Packaging Holding Corporation (NYSE:GPK)’s shares dropped -1.43% to $14.45, during the last trading session on Tuesday, as Graphic Packaging Holding Corporation, will release results for first quarter 2015 on Thursday, April 23rd before the market opens. The same morning, the corporation will host a conference call at 10:00 a.m. eastern to talk about first quarter results.
Graphic Packaging Holding Corporation, together with its auxiliaries, provides paper-based packaging solutions to food, beverage, and other consumer products companies.
At the end of Tuesday’s trade, Athersys, Inc. (NASDAQ:ATHX)‘s shares dipped -2.30% to $2.98, as Athersys, will release its first quarter 2015 financial results at about 4:00 PM EDT on Monday, May 11, 2015, and host a conference call shortly thereafter at 4:30 PM EDT to review the results.
Athersys, Inc., a biotechnology corporation, focuses on the research and development activities in the field of regenerative medicine. The corporation’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase II clinical trials for the treatment of ischemic stroke and inflammatory bowel disease (IBD); and that has accomplished Phase I clinical trial for the treatment of acute myocardial infarction and hematopoietic stem cell transplant/graft-as compared to-host disease.
Dunkin Brands Group Inc (NASDAQ:DNKN), ended its Tuesday’s trading session with -2.25% loss, and closed at $48.28, as Dunkin’ Brands Group, plans to release its first quarter 2015 financial results on Thursday, April 23, 2015, with a conference call to follow at 8:00 a.m. ET.
With more than 18,800 points of distribution in nearly 60 countries worldwide, Dunkin’ Brands Group, is one of the world’s leading franchisors of quick service restaurants (QSR) serving hot and cold coffee and baked goods, in addition to hard-serve ice cream. At the end of fiscal 2014, Dunkin’ Brands’ nearly 100 percent franchised business model comprised of more than 11,300 Dunkin’ Donuts restaurants and more than 7,500 Baskin-Robbins restaurants. Dunkin’ Brands Group, Inc. is headquartered in Canton, Mass.
Dunkin Brands Group, Inc., together with its auxiliaries, develops, franchises, and licenses quick service restaurants under the Dunkin Donuts and Baskin-Robbins brands worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
